Vip Viprakasit - Concepedia

Author

Vip Viprakasit

Also Known As

Anna Bárbara Carneiro-Proietti, V Viprakasit, V. VIPRAKASIT, V. Viprakasit, Vip Viprakasit, Vip Viprakasit, Vip Viprakasit (5659150), Yingyong Chinthammitr

308

Publications

8.1K

Citations

H-Index

109

Concepts

All Affiliations

Mahidol University Siriraj Hospital University College London Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico National and Kapodistrian University of Athens

About

Vip Viprakasit is an author at Mahidol University specializing in medicine, hematology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	2.2K
2	Health Sciences	11	12	438
3	Public Health	10	10	476
4	Natural Sciences	2	2	99
5	Engineering	1	1	12

Vip Viprakasit

100

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner Martin J. Law, Karen M. Lower, Hsiao P. J. Voon, Cell Size-dependent MannerAllelic VariantMendelian DisorderGenetic DisorderGenetics	2010	414
Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) Maria Domenica Cappellini, Alan R. Cohen, John B. Porter, MedicineTransfusion MedicineHematologyPatient SafetyBlood Transplantation	2014	403
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia Maria Domenica Cappellini, Vip Viprakasit, Alì Taher, New England Journal of Medicine	2020	289
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias Maria Domenica Cappellini, John B. Porter, Amal El‐Beshlawy, Haematologica	2009	284
A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter Marco De Gobbi, Vip Viprakasit, Jim R. Hughes, Science	2006	282
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin Hal Drakesmith, Lisa Schimanski, Emma Ormerod, Blood	2005	264
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations Lisa Schimanski, Hal Drakesmith, Alison T. Merryweather‐Clarke, Blood	2005	210
Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Blood	2009	194
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E Manit Nuinoon, Wattanan Makarasara, Taisei Mushiroda, Human Genetics Genome-wide Association StudyGenome-wide AssociationMedicineGeneticsHematology	2009	183
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study Alì Taher, John B. Porter, Vip Viprakasit, Blood	2012	141

Page 1